Toggle light / dark theme

Researchers from Carnegie Mellon and the University of Pittsburgh today published research showing how they’d solved a frustrating problem for people who use a brain-computer interface (BCI) to control prosthetic devices with their thoughts.

While the research itself is interesting – they created an algorithm that keeps the devices from constantly needing to be re-calibrated to handle the human brain’s fluctuating neuronal activity – the real takeaway here is how close we are to a universal BCI.

BCIs have been around for decades in one form or another, but they’re costly to maintain and difficult to keep working properly. Currently they only make sense for narrow use – specifically, in the case of those who’ve lost limbs. Because they’re already used to using their brain to control an appendage, it’s easier for scientists and researchers to harness those brainwaves to control prosthetic devices.

In a study published in Nature, a UCLA-led team of researchers describe how the nanomachine recognizes and kills bacteria, and report that they have imaged it at atomic resolution. The scientists also engineered their own versions of the nanomachine, which enabled them to produce variations that behaved differently from the naturally occurring version.

Their efforts could eventually lead to the development of new types of antibiotics that are capable of homing in on specific species of microbes. Drugs tailored to kill only a certain species or strain of bacteria could offer numerous advantages over conventional antibiotics, including lowering the likelihood that bacteria will develop resistance. In addition, the tailored drugs could destroy harmful cells without wiping out beneficial bugs in the gut microbiome, and they could eventually offer the possibilities of being deployed to prevent bacterial infections, to kill pathogens in food and to engineer human microbiomes so that favorable bacteria thrive.

The particle in the study, an R-type pyocin, is a protein complex released by the bacterium Pseudomonas aeruginosa as a way of sabotaging microbes that compete with it for resources. When a pyocin identifies a rival bacterium, it kills the bacterium by punching a hole in the cell’s membrane. P. aeruginosa, frequently a cause of hospital-acquired illness, is found in soil, in water and on fresh produce. The germ is commonly studied and its biology is well understood.

“Scientists have discovered an earlier origin to the human language pathway in the brain, pushing back its evolutionary origin by at least 20 million years.”

If you found this article informative and you’d like to share it, please “like” and share it from our Facebook page: https://m.facebook.com/story.php?story_fbid=570644296897252&id=383136302314720

Klotho has been called the “king of anti-aging proteins.” It is an important biomarker and promising gene therapy treatment for Chronic Kidney Disease. It is more strongly correlated with IQ than any single gene, making it a potential nootropic and intelligence enhancing gene therapy.

https://biovivascience.myshopify.com/blogs/news/klotho-queen…g-proteins

Massachusetts Institute of Technology (MIT) researchers have developed a series of soluble, stabilized cytokine receptors that could feasibly be injected into COVID-19 patients to help reduce the effects of cytokine storm by binding to excess cytokines.

#COVID19 #Coronavirus #Therapeutics


Independent research teams describe soluble cytokine receptors that might tackle cytokine storm, and suggest that a little known function of neutrophils may be involved in severe COVID-19 disease.